AK

Awais Khan Naim Khan

Active Director Director DIN 10210453
DIN 10210453 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value •••• Premium profile

About Awais Khan Naim Khan

Data last updated:

Awais Khan Naim Khan is a Director at Wansol Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Wansol Pharmaceuticals Private Limited reported revenue of ₹14.1 Lakh (FY 2025).

DIN 10210453
Primary Designation Director
Industry Pharma
First Appointment 22 Jun 2023
Oldest Company Age 3 yrs
Largest company Wansol Pharmaceuticals Private Limited · ₹14.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Jun 20232023₹14.1 Lakh (FY 2025)Active

Board colleagues of Awais Khan Naim Khan

NameDINCompanyDesignation
Ajmal Shah Shah Akil Ali10210454Wansol Pharmaceuticals Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Wansol Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Awais Khan Naim Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Awais Khan Naim Khan

Awais Khan Naim Khan currently holds 1 directorship: Wansol Pharmaceuticals Private Limited (Director, since 22 Jun 2023, revenue ₹14.1 Lakh (FY 2025)).

Awais Khan Naim Khan was first appointed on 22 Jun 2023 as Director at Wansol Pharmaceuticals Private Limited.

The current boards of Awais Khan Naim Khan's companies include Ajmal Shah Shah Akil Ali (Wansol Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available